000			02028 a2200577 4500
005			20250517052637.0
264		0	_c20160912
008			201609s 0 0 eng d
022			_a1476-5365
024	7		_a10.1038/bmt.2015.202 _2doi
040			_aNLM _beng _cNLM
100	1		_aKröger, N
245	0	0	_aAllogeneic stem cell transplantation after conditioning with treosulfan, etoposide and cyclophosphamide for patients with ALL: a phase II-study on behalf of the German Cooperative Transplant Study Group and ALL Study Group (GMALL). _h[electronic resource]
260			_bBone marrow transplantation _cDec 2015
300			_a1503-7 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAllografts
650	0	4	_aBusulfan _xadministration & dosage
650	0	4	_aCyclophosphamide _xadministration & dosage
650	0	4	_aEtoposide _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aGraft vs Host Disease _xetiology
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMyeloablative Agonists _xadministration & dosage
650	0	4	_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xmortality
650	0	4	_aStem Cell Transplantation
650	0	4	_aTransplantation Conditioning _xadverse effects
700	1		_aBornhäuser, M
700	1		_aStelljes, M
700	1		_aPichlmeier, U
700	1		_aTrenschel, R
700	1		_aSchmid, C
700	1		_aArnold, R
700	1		_aMartin, H
700	1		_aHeinzelmann, M
700	1		_aWolschke, C
700	1		_aMeyer, R G
700	1		_aBethge, W
700	1		_aKobbe, G
700	1		_aAyuk, F
700	1		_aGökbuget, N
700	1		_aHölzer, D
700	1		_aZander, A
700	1		_aBeelen, D
773	0		_tBone marrow transplantation _gvol. 50 _gno. 12 _gp. 1503-7
856	4	0	_uhttps://doi.org/10.1038/bmt.2015.202 _zAvailable from publisher's website
999			_c25258649 _d25258649